Clinical Trials in Washington

Showing 2941-2960 of 8,171 trials

Carisbamate Safety Study in Adult and Pediatric Subjects With Lennox-Gastaut Syndrome

NCT04062981

Open-label extension study from YKP509C001 to evaluate the safety and tolerability of carisbamate in subjects with Lennox-Gastaut Syndrome (LGS).

Lennox Gastaut Syndrome

SK Life Science, Inc.15 participantsStarted May 2019

Baltimore, Maryland, United States • Lebanon, New Hampshire, United States • Portland, Oregon, United States +2 more locations

COMPLETEDNA42 miles

DWI in Assessing Treatment Response in Patients With Breast Cancer Receiving Neoadjuvant Chemotherapy

NCT01564368

RATIONALE: Imaging procedures, such as diffusion-weighted magnetic resonance imaging (DWI) and dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI), may help in evaluating how well patients with breast cancer respond to treatment. PURPOSE: This research trial studies DWI and DCE-MRI in assessing treatment response in patients with breast cancer undergoing neoadjuvant chemotherapy.

Breast Cancer

American College of Radiology Imaging Network406 participantsStarted Aug 2012

Birmingham, Alabama, United States • San Francisco, California, United States • Minneapolis, Minnesota, United States +4 more locations

Carisbamate Safety Study in Adult and Pediatric Subjects With Lennox-Gastaut Syndrome

DWI in Assessing Treatment Response in Patients With Breast Cancer Receiving Neoadjuvant Chemotherapy

Find Trials by Condition in Washington

Open-Label Extension Study of Trofinetide for the Treatment of Girls and Women With Rett Syndrome

Cancer Stem Cell High-Throughput Drug Screening Study

Romidepsin and Lenalidomide in Treating Patients With Previously Untreated Peripheral T-Cell Lymphoma

Allogeneic Heart Stem Cells to Achieve Myocardial Regeneration

A Pilot RCT of the PRISM Intervention for AYAs With Cancer

Study of Trofinetide for the Treatment of Girls and Women With Rett Syndrome (LAVENDER™)

Allogeneic Natural Killer (NK) Cell Therapy in Subjects Hospitalized for COVID-19

A Study Evaluating the Safety, Pharmacokinetics, and Clinical Effects of Intravenously Administered PT-112 Injection in Subjects With Advanced Solid Tumors and Subsequent Dose Expansion Cohorts

Chronic Obstructive Pulmonary Disease and Community Health Worker Home-visits

Spiration Valves Against Standard Therapy

TAC/MTX vs. TAC/MMF/PTCY for Prevention of Graft-versus-Host Disease and Microbiome and Immune Reconstitution Study (BMT CTN 1703/1801)

Palbociclib (PD-0332991) Combined With Fulvestrant In Hormone Receptor+ HER2-Negative Metastatic Breast Cancer After Endocrine Failure (PALOMA-3)

Geriatric Assessment Intervention for Reducing Toxicity in Older Patients With Advanced Cancer

A Study of MRx-4DP0004 in Asthma

Study to Compare the Efficacy and Safety of Enzyme Replacement Therapies Avalglucosidase Alfa and Alglucosidase Alfa Administered Every Other Week in Patients With Late-onset Pompe Disease Who Have Not Been Previously Treated for Pompe Disease

Combination Chemotherapy and Cyclosporine Followed by Focal Therapy for Bilateral Retinoblastoma

Safety and Effectiveness of GP0112 for Cheek Augmentation and Correction of Midface Contour Deficiencies

An Open-Label, Single Arm Study of Obinutuzumab Short Duration Infusion in Patients With Previously Untreated Advanced Follicular Lymphoma